Evidence map›Paper›PMID 25493445›Full record

ArticleNature communications2014

Regulation of tyrosine hydroxylase transcription by hnRNP K and DNA secondary structure.

Kasturi Banerjee, Meng Wang, Elizabeth Cai, Nana Fujiwara, Harriet Baker, John W Cave

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kasturi BanerjeeBurke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, New York 10605, USA.
Meng WangBurke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, New York 10605, USA.
Elizabeth CaiBurke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, New York 10605, USA.
Nana FujiwaraBurke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, New York 10605, USA.
Harriet Baker1] Burke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, New York 10605, USA [2] Brain and Mind Research Institute, Weill Cornell Medical College, New York, New York 10021, USA.
John W Cave1] Burke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, New York 10605, USA [2] Brain and Mind Research Institute, Weill Cornell Medical College, New York, New York 10021, USA.
Burke Medical Research Institute · USCornell University · US

Funding

Plasticity in the Aging Olfactory SystemR01DC008955 · NIDCD · WINIFRED MASTERSON BURKE MED RES INST · PI BAKER, HARRIET D., CAVE, JOHN W · 2008 to 2015
$4.6M
NIDCD NIH HHS R01 DC008955
6 · The paper itself

Abstract

Regulation of tyrosine hydroxylase gene (Th) transcription is critical for specifying and maintaining the dopaminergic neuronal phenotype. Here we define a molecular regulatory mechanism for Th transcription conserved in tetrapod vertebrates. We show that heterogeneous nuclear ribonucleoprotein (hnRNP) K is a transactivator of Th transcription. It binds to previously unreported and evolutionarily conserved G:C-rich regions in the Th proximal promoter. hnRNP K directly binds to C-rich single-stranded DNA within these conserved regions and also associates with double-stranded sequences when proteins, such as CRE-binding protein, are bound to an adjacent cis-regulatory element. The single DNA strands within the conserved G:C-rich regions adopt either G-quadruplex or i-motif secondary structures. We also show that small molecule-mediated stabilization of these secondary structures represses Th promoter activity. These data suggest that these secondary structures are targets for pharmacological modulation of the dopaminergic phenotype.

Identifiers

PMID25493445
PMCPMC4264680
OpenAlexW2040852539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.